Bioventus Inc Stock (BVS) Financials Data
*All numbers in millions
| Period End Date | 2026-09-26 | 2026-06-27 | 2026-03-28 | 2025-12-31 | 2025-09-27 |
|---|---|---|---|---|---|
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues | 7.03%142.44 | 153.21 | 132.09 | 157.90 | 138.65 |
| Cost Of Revenue | 4.69%45.31 | 47.54 | 41.32 | 49.12 | 44.42 |
| Gross Profit | 8.08%97.13 | 105.67 | 90.77 | 108.78 | 94.23 |
0.25%82.95 | 82.74 | 78.33 | - | - | |
| Selling, General, and Administrative | 0.25%82.95 | 82.74 | 78.33 | - | - |
| Research and Development | 8.26%3.44 | 3.17 | 2.47 | - | - |
| Depreciation and Amortization | 0.67%1.05 | 1.04 | 1.11 | 1.30 | 1.40 |
| Operating Income/Loss | 49.29%9.70 | 19.13 | 8.42 | 19.49 | 11.25 |
| Nonoperating Income/Loss | 7.25%-3.54 | -3.82 | -3.90 | -5.34 | -6.58 |
| Income/Loss From Continuing Operations Before Tax | 59.77%6.16 | 15.31 | 4.52 | 14.14 | 4.67 |
| Income Tax Expense/Benefit | 96.65%-0.70 | -20.90 | 0.57 | -3.18 | 0.66 |
81.06%6.86 | 36.21 | 3.95 | 17.32 | 4.01 | |
| Attributable To Parent | 82.10%5.99 | 33.44 | 3.11 | 14.76 | 3.16 |
| Attributable To Noncontrolling Interest | 68.45%0.87 | 2.76 | 0.83 | 2.56 | 0.85 |
| Basic Average Shares | 0.75%68.38 | 67.87 | 67.30 | 0.14 | 66.92 |
| Diluted Average Shares | 2.34%72.49 | 70.84 | 70.01 | 0.12 | 68.84 |
| Basic Earnings Per Share | 81.63%0.09 | 0.49 | 0.05 | 0.22 | 0.05 |
| Diluted Earnings Per Share | 82.98%0.08 | 0.47 | 0.04 | 0.21 | 0.05 |